Skip to main navigation Skip to search Skip to main content

A phase 2/3 interventional safety pharmacokinetics and efficacy open label multi center single arm study to investigate orally administered PF-0732133

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date03/10/22 → 03/9/27

Funding

  • Pfizer Incorporated: $40,600.00